IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Healthcare Services Group, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire

LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Healthcare Services Group, Inc. (“Healthcare Services” or “the Company”) (NASDAQ: HCSG) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's shares between April 11, 2017 and March 4, 2019, inclusive (the "Class Period"), are encouraged to contact the firm before May 21, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Healthcare Services knew or recklessly failed to understand that the Company was accused of manipulating quarterly earnings per share, which meant shareholders could not rely on the Company’s historical performance until an investigation into these allegations was complete. In fact, Healthcare Services concealed from the public that the SEC had written a letter to the Company in November 2017 inquiring into the Company’s practice of rounding its earnings per share. The Company also concealed an SEC subpoena delivered in March 2018 which demanded documentation of its earnings per share calculations. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Healthcare Services, investors suffered damages.